Literature DB >> 15948253

Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide.

Qin-Shu Shao1, Zai-Yuan Ye, Zhi-Qiang Ling, Jin-Jing Ke.   

Abstract

AIM: To investigate the effect of arsenic trioxide on human gastric cancer cell line MKN45 with respect to both cytotoxicity and induction of apoptosis in vitro.
METHODS: MKN45 cells were treated with arsenic trioxide (As2O3) at the concentration of 1, 5, and 10 micromol/L, respectively, for three successive days. Cell growth and proliferation were observed by cell counting and trypan blue exclusion. Cytotoxicity of As2O3 was determined by MTT assay. Morphologic changes were studied with light microscopy. Flow cytometry was used to assay cell DNA distribution and apoptotic cells were confirmed with terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and DNA electrophoresis.
RESULTS: The growth of MKN45 cells was significantly inhibited by As2O3 which was confirmed by colony-forming assay. After 7 d of culture with various concentrations of As2O3, colony-forming capacity of MKN45 cells decreased with As2O3 increment in comparison with that of control group. The inhibitory rate of colony-formation was 38.5%, 99.1%, and 99.5% when the concentration of As2O3 was 1, 5, and 10 micromol/L in culture medium, respectively. The cell number of a single colony in drug treatment groups was less than that of control group. The cell-killing rate of As2O3 to MKN45 cells was both dose- and time-dependent with an IC50 of (11.05+/-0.25) micromol/L. After incubation in 10 micromol/L As2O3 for 24 h, the cell-killing rate was 27.1%, and it was close to 50% after 48 h. The results showed that As2O3 induced time- and dose-dependent apoptosis in MKN45 cells, blocked at G2/M phase. The apoptotic peak (sub-G1 phase) appeared and cell apoptotic rate in MKN45 cells was 18.3-32.5% after treatment by 10 micromol/L As2O3 for 48 h. The percentage of G2/M cell of the experimental groups was 2.0-5.0 times than that of the control group. Gel electrophoresis of DNA from cells treated with each concentration of As2O3 for 48 h revealed a "ladder" pattern, indicating preferential DNA degradation at the internucleosomal, linker DNA sections. TUNEL also demonstrated strand breaks in DNA of MKN45 cells treated with As2O3, while control cells showed negative labeling.
CONCLUSION: As2O3 can induce apoptosis of human gastric carcinoma cells MKN45, which is the basis of its effectiveness. It shows great potential in the treatment of gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948253      PMCID: PMC4316002          DOI: 10.3748/wjg.v11.i22.3451

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

1.  Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.

Authors:  Woo Hyun Park; Yeon Hee Cho; Chul Won Jung; Joon Oh Park; Kihyun Kim; Young Hyuck Im; Mark H Lee; Won Ki Kang; Keunchil Park
Journal:  Biochem Biophys Res Commun       Date:  2003-01-03       Impact factor: 3.575

2.  Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.

Authors:  P Jia; G Chen; X Huang; X Cai; J Yang; L Wang; Y Zhou; Y Shen; L Zhou; Y Yu; S Chen; X Zhang; Z Wang
Journal:  Chin Med J (Engl)       Date:  2001-01       Impact factor: 2.628

3.  Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells.

Authors:  J G Seol; W H Park; E S Kim; C W Jung; J M Hyun; Y Y Lee; B K Kim
Journal:  Int J Oncol       Date:  2001-02       Impact factor: 5.650

4.  Arsenic enhances the activation of Stat1 by interferon gamma leading to synergistic expression of IRF-1.

Authors:  Mounira K Chelbi-alix; Pierre Bobé; Gerard Benoit; Antony Canova; Richard Pine
Journal:  Oncogene       Date:  2003-12-11       Impact factor: 9.867

5.  Arsenic trioxide selectively induces early and extensive apoptosis via the APO2/caspase-8 pathway engaging the mitochondrial pathway in myeloma cells with mutant p53.

Authors:  Cagla Akay; Yair Gazitt
Journal:  Cell Cycle       Date:  2003 Jul-Aug       Impact factor: 4.534

6.  Hydrogen peroxide in the Burkitt's lymphoma cell line Raji provides protection against arsenic trioxide-induced apoptosis via the phosphoinositide-3 kinase signalling pathway.

Authors:  Di Lu; Xiao-Chun Bai; Li Gui; Yong-Chun Su; Fan Deng; Bin Liu; Xiu-Mei Li; Wei-Sen Zeng; Bao-Luan Cheng; Shen-Qiu Luo
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

7.  Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C).

Authors:  Laurence Michel; Alain Dupuy; Francette Jean-Louis; Aurore Sors; Joël Poupon; Manuelle Viguier; Philippe Musette; Louis Dubertret; Laurent Degos; Hervé Dombret; Hervé Bachelez
Journal:  J Invest Dermatol       Date:  2003-10       Impact factor: 8.551

8.  Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.

Authors:  Xiao-Mei Hu; Toshihiko Hirano; Kitaro Oka
Journal:  Cancer Chemother Pharmacol       Date:  2003-05-16       Impact factor: 3.333

9.  Phosphorylation of PML by mitogen-activated protein kinases plays a key role in arsenic trioxide-mediated apoptosis.

Authors:  Fumihiko Hayakawa; Martin L Privalsky
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

10.  Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.

Authors:  Philippe Rousselot; Jérôme Larghero; Sylvaine Labaume; Joël Poupon; Martine Chopin; Christine Dosquet; Jean-Pierre Marolleau; Anne Janin; Jean-Claude Brouet; Jean-Paul Fermand
Journal:  Eur J Haematol       Date:  2004-03       Impact factor: 2.997

View more
  10 in total

1.  Effect of As2O3 on colorectal CSCs stained with ALDH1 in primary cell culture in vitro.

Authors:  Ke Ning; Wenlong Ning; Xiaoting Ning; Xueyan Wang; Fei Zhou
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

2.  Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45 gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism.

Authors:  Zhi-Hong Yu; Pin-Kang Wei; Ling Xu; Zhi-Feng Qin; Jun Shi
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

3.  Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.

Authors:  Erika B Dugo; Clement G Yedjou; Jacqueline J Stevens; Paul B Tchounwou
Journal:  Ann Clin Pathol       Date:  2017-01-04

4.  Arsenic trioxide inhibits cholangiocarcinoma cell growth and induces apoptosis.

Authors:  Fei Zhong; Shineng Zhang; Chunkui Shao; Jing Yang; Xiangyuan Wu
Journal:  Pathol Oncol Res       Date:  2009-12-12       Impact factor: 3.201

5.  The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.

Authors:  Yihu Zheng; Mengtao Zhou; Aifang Ye; Qiu Li; Yongheng Bai; Qiyu Zhang
Journal:  World J Surg Oncol       Date:  2010-04-20       Impact factor: 2.754

6.  Thioredoxin-1 inhibitor PX-12 induces human acute myeloid leukemia cell apoptosis and enhances the sensitivity of cells to arsenic trioxide.

Authors:  Yingxia Tan; Laixi Bi; Peili Zhang; Fule Wang; Feiyan Lin; Wuhua Ni; Jianbo Wu; Lei Jiang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

7.  Characterization and Identification of Cryptic Biopeptides in Carya illinoinensis (Wangenh K. Koch) Storage Proteins.

Authors:  Everardo Mares-Mares; Santiago Gutiérrez-Vargas; Luis Pérez-Moreno; Leandro G Ordoñez-Acevedo; José E Barboza-Corona; Ma Fabiola León-Galván
Journal:  Biomed Res Int       Date:  2017-11-27       Impact factor: 3.411

8.  Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.

Authors:  Runchen Miao; Xinsen Xu; Zhixin Wang; Sushun Liu; Kai Qu; Wei Chen; Chang Liu
Journal:  Mol Med Rep       Date:  2017-12-22       Impact factor: 2.952

9.  Effects of the combination of As2O3 and AZT on proliferation inhibition and apoptosis induction of hepatoma HepG2 cells following silencing of Egr-1.

Authors:  Chuan Zhao; Mei Wang; Yu Liu; Yongjuan Liang; Li Han; Che Chen
Journal:  Onco Targets Ther       Date:  2018-06-01       Impact factor: 4.147

10.  Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.

Authors:  Tongsen Zheng; Dalong Yin; Zhaoyang Lu; Jiabei Wang; Yuejin Li; Xi Chen; Yingjian Liang; Xuan Song; Shuyi Qi; Boshi Sun; Changming Xie; Xianzhi Meng; Shangha Pan; Jiaren Liu; Hongchi Jiang; Lianxin Liu
Journal:  Mol Cancer       Date:  2014-05-31       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.